Citigroup’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-24
| Closed | -$79 | – | 4752 |
|
|
2024
Q4 | $79 | Buy |
+24
| New | +$79 | ﹤0.01% | 4827 |
|
|
2022
Q2 | – | Sell |
-25
| Closed | -$1K | – | 5372 |
|
|
2022
Q1 | $1K | Buy |
+25
| New | +$1K | ﹤0.01% | 5307 |
|
|
2021
Q4 | – | Sell |
-55
| Closed | -$6K | – | 5009 |
|
|
2021
Q3 | $6K | Sell |
55
-9
| -14% | -$982 | ﹤0.01% | 4802 |
|
|
2021
Q2 | $6K | Sell |
64
-38
| -37% | -$3.56K | ﹤0.01% | 5108 |
|
|
2021
Q1 | $10K | Sell |
102
-45
| -31% | -$4.41K | ﹤0.01% | 4954 |
|
|
2020
Q4 | $14K | Buy |
147
+108
| +277% | +$10.3K | ﹤0.01% | 4765 |
|
|
2020
Q3 | $19K | Sell |
39
-94
| -71% | -$45.8K | ﹤0.01% | 3983 |
|
|
2020
Q2 | $103K | Buy |
133
+37
| +39% | +$28.7K | ﹤0.01% | 3437 |
|
|
2020
Q1 | $67K | Buy |
96
+31
| +48% | +$21.6K | ﹤0.01% | 3561 |
|
|
2019
Q4 | $59K | Buy |
+65
| New | +$59K | ﹤0.01% | 3849 |
|